Jura M, Kozak LP (2016) Obesity and related consequences to ageing. Age 38:23
Article PubMed PubMed Central Google Scholar
Salvestrini V, Sell C, Lorenzini A (2019) Obesity may accelerate the aging process. Front endocrinol 10:266
Matsuzawa Y, Funahashi T, Nakamura T (2011) The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb 18:629–639
Article CAS PubMed Google Scholar
Yokokawa H, Fukuda H, Saita M, Goto K, Kaku T, Miyagami T, Takahashi Y, Hamada C, Hisaoka T, Naito T (2021) An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects. Diabetol Metab Syndr 13:44
Article PubMed PubMed Central Google Scholar
Zou Y, Sheng G, Yu M, Xie G (2020) The association between triglycerides and ectopic fat obesity: an inverted U-shaped curve. PLoS ONE 15:e0243068
Article CAS PubMed PubMed Central Google Scholar
The Ministry of Health, Labour and Welfare, Japan. crude drugs and related drugs in japanese pharamopoeia eighteenth edition (JP XVIII), English Version (2021) Bofutsushosan Extract, pp 1961–1965, Published on the Internet; https://www.mhlw.go.jp/content/11120000/000912390.pdf. Accessed on: 4 Mar 2024
Hioki C, Yoshimoto K, Yoshida T (2004) Efficacy of bofutsushosan, an oriental herbal medicine, in obese Japnese women with impaired glucose tolerance. Clin Exp Pharmacol Physiol 31:614–619
Article CAS PubMed Google Scholar
Hioki C, Arai M (2007) Bofutsushosan use for obesity with IGT: search for scientific basis and development of effective therapy with Kampo medicine. J Trad Med 24:115–127
Azushima K, Tamura K, Haku S, Wakui H, Kanaoka T, Ohsawa M, Uneda K, Kobayashi R, Ohki K, Dejima T, Maeda A, Hashimoto T, Oshikawa J, Kobayashi Y, Nomura K, Azushima C, Takeshita Y, Fujino R, Uchida K, Shibuya K, Ando D, Tokita Y, Fijikawa T, Toya Y, Umemura S (2015) Effects of the oriental herbal medicine Bofutsuchosan in obesity hypertension: a multicenter, randomized, parallel-group controlled trial. Atherosclerosis 240:297–304
Article CAS PubMed Google Scholar
Uneda K, Kawai Y, Yamada T, Kaneko A, Saito R, Chen L, Ishigami T, Namiki T, Mitsuma T (2022) Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: a systematic review and meta-analysis. PLoS ONE 17:e0266917
Article CAS PubMed PubMed Central Google Scholar
Park J, Bose S, Hong S-W, Lee D-K, Yoo J-W, Lim C-Y, Lee M, Kim H (2014) Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3’UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. J Med Food 17:558–570
Article CAS PubMed PubMed Central Google Scholar
Akaki J, Tanaka T, Arai T, Yamasaki H, Nakajima M (2019) Effects of bofutsushosan extract tablet, OTC Kampo formulation, on abdominal visceral fat reduction. J New Rem Clin 68:766–779
Yoshida T, Sakane N, Wakabayashi Y, Umekawa T, Kondo M (1995) Thermogenic, anti-obesity effects of bofu-tsusho-san in MSG-obese mice. Int J Obes Relat Metab Disord 19:717–722
Morimoto Y, Sakata M, Ohno A, Maegawa T, Tajima S (2001) Effects of bofutsushosan, a traditional Chinese medicine, on body fat accumulation in fructose-loaded rats. Folia Pharmacol Jpn 117:77–86
Ohno K, Chung H-J, Maruyama I, Tani T (2005) Bofutsushosan, a traditional Chinese formulation, prevents intimal thickening and vascular smooth muscle cell proliferation induced by balloon endothelial denudation in rats. Biol Pharm Bull 28:2162–2165
Article CAS PubMed Google Scholar
Saito M, Hamazaki T, Tani T, Watanabe S (2005) Bofutsushosan, a traditional Chinese formulation, inhibits pancreatic lipase activity in vitro and suppresses the elevation of plasma triacylglycerols after oral administration of lipid emulsion. J Trad Med 22:308–313
Sakamoto S, Takeshita S, Sassa S, Suzuki S, Ishikawa Y, Kudo H (2005) Effects of colestimide and/or bofu-tsusho-san on plasma and liver lipids in mice fed a high-fat diet. In Vivo 19:1029–1033
Shimada T, Kudo T, Akase T, Aburada M (2008) Preventive effects of bofutsushosan on obesity and various metabolic disorders. Biol Pharm Bull 31:1362–1367
Article CAS PubMed Google Scholar
Yamakawa J, Ishigaki Y, Takano F, Takahashi T, Yoshida J, Moriya J, Takata T, Tatsuno T, Sasaki K, Ohta T, Takegami T, Yoshizaki F (2008) The Kampo medicines orengedokuto, bofutsushosan and boiogito have different activities to regulate gene expression in differentiated rat white adipocytes: comprehensive analysis of genetic profiles. Biol Pharm Bull 31:2083–2089
Article CAS PubMed Google Scholar
Akagiri S, Naito Y, Ichikawa H, Mizushima K, Takagi T, Handa O, Kokura S, Yoshikawa T (2008) Bofutsushosan, an oriental herbal medicine, attenuates the weight gain of white, adipose tissue and the increased size of adipocytes associated with the increase in their expression of uncoupling protein 1 in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 42:158–166
Article PubMed PubMed Central Google Scholar
Azushima K, Tamura K, Wakui H, Maeda A, Ohsawa M, Uneda K, Kobayashi R, Kanaoka T, Dejima T, Fujikawa T, Yamashita A, Toya Y, Umemura S (2013) Bofutsushosan, an oriental herbal medicine, exerts a combinatorial favorable metamobic modulation including antihypertensive effect on a mouse model of human metabolic disorders with visceral obesity. PLoS ONE 8:e75560
Article CAS PubMed PubMed Central Google Scholar
Yu Q, Takahashi T, Nomura M, Kobayashi S (2013) Anti-hyperglycemic effect of single administrated Gardenia Fructus in streptozotocin-induced diabetic mice by improving insulin resistance and enhancing glucose uptake in skeletal muscle. Clin Med 4:157–165
Ono M, Ogasawara M, Hirose A, Mogami S, Ootake N, Aritake K, Higuchi T, Okamoto N, Sakamoto S, Yamamoto M, Urade Y, Saibara T, Oben JA (2014) Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice. J Gastroenterol 49:1065–1073
Lin CH, Kuo YH, Shih CC (2014) Effects of bofu-tsusho-san on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice. Int J Mol Sci 15:20022–20044
Article CAS PubMed PubMed Central Google Scholar
Qian W, Hasegawa J, Tsuno S, Endo Y, Matsuda A, Miura N (2014) Effects of kampo formulas on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. Yonago Acta Med 57:147–158
PubMed PubMed Central Google Scholar
Kobayashi S, Kawasaki Y, Maeno H, Nomura M (2017) Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice. Chin Med 12:8
Article PubMed PubMed Central Google Scholar
Yu Q, Takahashi T, Nomura M, Matsuo-Ikeda Y, Kobayashi S (2017) Mechanism of Gardeniae fructus for the anti-diabetic action in high-fat diet-fed and streptozotocin-treated diabetic mice. Asian J Trad Med 12:19–30
Kobayashi S (2018) Pharmacological mechanisms of boiogito and bofutsushosan in diabetes and obesity models. Yakugaku Zasshi 138:389–403
Article CAS PubMed Google Scholar
Akaki J, Tachi S, Nakamura N, Arai T, Yamasaki H, Inoue M, Makino T (2018) Promotive effect of bofutsushosan (fangfengtongshengsan) on lipid and cholesterol excretion in faces in mice treated with a high-fat diet. J Ethnopharmacol 220:1–8
Gao S, Satsu H, Makino T (2018) Inhibitory effect of bofutsushosan (fang feng tong sheng san) on glucose transporter 5 function in vitro. J Nat Med 72:530–536
Fujisaka S, Usui I, Nawaz A, Igarashi Y, Okabe K, Furusawa Y, Watanabe S, Yamamoto S, Sasahara M, Watanabe Y, Nagai Y, Yagi K, Nakagawa T, Tobe K (2020) Bofutsushosan improves gut barrier function with a bloom of Akkermansia muciniphila and improves glucose metabolism in mice with diet-induced obesity. Sci Rep 10:5544
Article CAS PubMed PubMed Central Google Scholar
Nishiyama M, Ohtake N, Kaneko A, Tsuchiya N, Imamura S, Iizuka S, Ishikawa S, Nishi A, Yamamoto M, Taketomi A, Kono T (2020) Increase of Akkermansia muciniphila by a diet containing Japanese traditional medicine bofutsushosan in a mouse of non-alcoholic fatty liver disease. Nutrients 12:839
Comments (0)